• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于哺乳动物细胞化学诱导损伤恢复的研究。

Studies on recovery from chemically induced damage in mammalian cells.

作者信息

Barranco S C, Novak J K, Humphrey R M

出版信息

Cancer Res. 1975 May;35(5):1194-204.

PMID:47265
Abstract

The survival of plateau-phase or nondividing Chinese hamster ovary cells (in vitro) is reduced to a greater extent by treatments with nitrosourea compounds than are cells treated in the exponential phase of growth. The greatest decrease in the survival fraction occurred following treatments with 1-trans-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea where approximately 128 times more cells were killed in plateau phase than in the dividing state (at the 10 mug/ml-for-1-hr dose). Only 5 times more cells were killed in plateau phase than in exponential growth when cells were treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Cells treated with either nitrosourea compound failed to recover from potentially lethal damage and sublethal damage. The breakdown products of the nitrosourea compounds are known to inhibit DNA repair and may explain the failure of mammalian cells to recover from sublethal damage and potentially lethal damage induced by these chemicals. Both dividing and nondividing cells were able to recover from bleomycin-induced potentially lethal damage but not from sublethal damage. The recovery from bleomycin-induced potentially lethal damage by nondividing cells was twice as great as that exhibited by dividing cells; however, potentially lethal damage recovery was suffieiently high for cells in both growth states to conceal the true response to sublethal damage.

摘要

与处于指数生长期的细胞相比,亚硝基脲化合物处理对处于平台期或不分裂的中国仓鼠卵巢细胞(体外)的存活率降低程度更大。在用1-反式-(2-氯乙基)-3-(4-甲基环己基)-1-亚硝基脲处理后,存活分数下降最大,在平台期被杀死的细胞数量大约是分裂状态下(在10微克/毫升处理1小时的剂量下)的128倍。当用1-(2-氯乙基)-3-环己基-1-亚硝基脲处理时,平台期被杀死的细胞数量仅比指数生长期多5倍。用这两种亚硝基脲化合物处理的细胞均未能从潜在致死损伤和亚致死损伤中恢复。已知亚硝基脲化合物的分解产物会抑制DNA修复,这可能解释了哺乳动物细胞无法从这些化学物质诱导的亚致死损伤和潜在致死损伤中恢复的原因。分裂细胞和不分裂细胞都能够从博来霉素诱导的潜在致死损伤中恢复,但不能从亚致死损伤中恢复。不分裂细胞从博来霉素诱导的潜在致死损伤中的恢复程度是分裂细胞的两倍;然而,两种生长状态下细胞的潜在致死损伤恢复程度都足够高,从而掩盖了对亚致死损伤的真实反应。

相似文献

1
Studies on recovery from chemically induced damage in mammalian cells.关于哺乳动物细胞化学诱导损伤恢复的研究。
Cancer Res. 1975 May;35(5):1194-204.
2
Response of mammalian cells to bleomycin-induced potentially lethal and sublethal damage.
Prog Biochem Pharmacol. 1976;11:78-92.
3
Modification of the response to actinomycin D-induced sublethal damage by simultaneous recovery from potentially lethal damage in mammalian cells.通过在哺乳动物细胞中从潜在致死性损伤同时恢复来改变对放线菌素D诱导的亚致死性损伤的反应。
Cancer Res. 1976 May;36(5):1634-40.
4
Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression.三种亚硝基脲衍生物对哺乳动物细胞周期进程的比较作用。
Cancer Res. 1975 Feb;35(2):460-70.
5
Cell cycle phase recovery from bleomycin-induced potentially lethal damage.
Cancer Res. 1977 Aug;37(8 Pt 1):2589-91.
6
Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives.指数生长期、稳定期及同步培养的人结肠癌细胞对亚硝基脲衍生物处理的反应。
Cancer Res. 1979 Jul;39(7 Pt 1):2630-6.
7
A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.三种亚硝基脲衍生物对培养的人淋巴瘤细胞致死效应的比较。
Cancer Res. 1976 Feb;36(2 Pt 1):511-5.
8
Repair following combined X-ray and heat at 41 degrees in plateau-phase mammalian cells.处于平台期的哺乳动物细胞在41摄氏度下经X射线和加热联合处理后的修复情况。
Cancer Res. 1977 Sep;37(9):3374-8.
9
Effect of hypoxia on recovery from damage induced by heat and radiation in plateau-phase CHO cells.缺氧对平台期中国仓鼠卵巢细胞热损伤和辐射损伤恢复的影响。
Radiat Res. 1985 Feb;101(2):312-25.
10
Cellular response to treatment with 4-(3-(2-chloroethyl)-3-nitrosoureido)-cis-cyclohexanecarboxylic acid, a water-soluble nitrosourea derivative.细胞对4-(3-(2-氯乙基)-3-亚硝基脲基)-顺式环己烷羧酸(一种水溶性亚硝基脲衍生物)治疗的反应。
Cancer Treat Rep. 1977 Nov;61(8):1513-8.

引用本文的文献

1
The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.衔接整合因子1(BIN1)在阿尔茨海默病中的作用机制
Cell Mol Neurobiol. 2021 Oct;41(7):1431-1440. doi: 10.1007/s10571-020-00926-y. Epub 2020 Jul 27.
2
Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.米索硝唑增强洛莫司汀的细胞毒性:可能的治疗获益。
Br J Cancer. 1982 Jul;46(1):109-16. doi: 10.1038/bjc.1982.172.
3
In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitol.
人星形细胞瘤克隆对氯乙基亚硝脲和双去水半乳糖醇的体外细胞特性及存活反应
Invest New Drugs. 1983;1(2):129-37. doi: 10.1007/BF00172071.
4
Heterogeneous responses of an in vitro model of human stomach cancer to anticancer drugs.人胃癌体外模型对抗癌药物的异质性反应。
Invest New Drugs. 1983;1(2):117-27. doi: 10.1007/BF00172070.
5
Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells.抗雌激素他莫昔芬的亚硝基脲和亚硝基氨基甲酸酯衍生物作为人乳腺癌细胞中潜在的雌激素受体介导的细胞毒性剂。
Breast Cancer Res Treat. 1986;7(2):77-90. doi: 10.1007/BF01806792.
6
Heterogeneous survival responses of human gastric cancer clones to alpha difluoromethylornithine in vitro.人胃癌克隆对α-二氟甲基鸟氨酸的体外异质性存活反应。
Invest New Drugs. 1986;4(4):337-45. doi: 10.1007/BF00173506.
7
Augmentation of fibroblast proliferation by bleomycin.博来霉素对成纤维细胞增殖的增强作用。
J Clin Invest. 1986 Nov;78(5):1150-4. doi: 10.1172/JCI112695.
8
Responses of proliferating and non-proliferating Chinese hamster cells to cytotoxic agents.增殖和非增殖中国仓鼠细胞对细胞毒性剂的反应。
Br J Cancer. 1978 Mar;37(3):377-85. doi: 10.1038/bjc.1978.57.
9
The effects of 1-methyl-1-nitrosourea on the survival pattern of cycling and noncycling HeLa cells.1-甲基-1-亚硝基脲对增殖期和非增殖期HeLa细胞存活模式的影响。
J Cancer Res Clin Oncol. 1979 Jul 27;94(3):265-75. doi: 10.1007/BF00419286.
10
The effect of fractionated exposure to thio-TEPA upon Chinese hamster cells in vitro.
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Dec 9;87(3):301-9. doi: 10.1007/BF00506503.